BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Golounina OO, Dzeranova LK, Pigarova EA, Belaya ZE. Resistance to drug treatment of acromegaly and ways to overcome it. Obes metabol 2021;18:150-162. [DOI: 10.14341/omet12710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Nurullina GM, Akhmadullina GI, Maslova IS, Nikolaeva AR. Clinical characteristics and efficacy of acromegaly treatment in the Udmurt Republic. Almanac of Clinical Medicine 2022;50:170-176. [DOI: 10.18786/2072-0505-2022-50-037] [Reference Citation Analysis]
2 Ilovayskaya IA. Octreotide in the treatment of acromegaly – the possibilities of high-dose therapy. Medicinskij sovet 2022. [DOI: 10.21518/2079-701x-2022-16-10-148-152] [Reference Citation Analysis]
3 Krysanov IS, Makarova EV, Ermakova VY. COMPARATIVE PHARMACOECONOMIC ANALYSIS OF LONG-ACTING LANREOTIDE USED IN ACROMEGALY THERAPY WITHIN CONDITIONS OF THE RUSSIAN FEDERATION HEALTH CARE SYSTEM. Farm farmakol (Pâtigorsk) 2022;10:164-173. [DOI: 10.19163/2307-9266-2022-10-2-164-173] [Reference Citation Analysis]